Prior to joining Cleerly, Hartman was vice president (VP) of sales and the team leader for third-party administrators and resellers at Teladoc Health after its merger with Livongo Health. At Livongo, Hartman built and led a U.S. health system team focused on commercial sales to health systems as employers and health plan providers prior to its $3.4 billion IPO in 2019. Prior to Livongo, Hartman served as VP of sales at Maquet Getinge Group and oversaw a $500 million annual business across several product divisions, including cardiovascular interventions. Hartman also directed sales for Maquet’s cardiac and vascular surgery, cardiology, cardiopulmonary and critical care divisions. Additionally, he commercialized traditional cardiac surgery and emerging technologies at Guidant Cardiac Surgery and Boston Scientific after his time at TAP Pharmaceuticals.
Hartman holds a Master of Business Administration from New York University’s Stern School of Business and a Bachelor of Business Administration in corporate finance from Stetson University.
